GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Other Stockholders Equity

Chordia Therapeutics (TSE:190A) Other Stockholders Equity : 円2.52 Mil (As of Feb. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Other Stockholders Equity?

Chordia Therapeutics's Other Stockholders Equity for the quarter that ended in Feb. 2025 was 円2.52 Mil.

Chordia Therapeutics's quarterly Other Stockholders Equity declined from May. 2024 (円25.93 Mil) to Aug. 2024 (円2.94 Mil) and declined from Aug. 2024 (円2.94 Mil) to Feb. 2025 (円2.52 Mil).

Chordia Therapeutics's annual Other Stockholders Equity declined from Aug. 2022 (円5,432.87 Mil) to Aug. 2023 (円25.93 Mil) and declined from Aug. 2023 (円25.93 Mil) to Aug. 2024 (円2.94 Mil).


Chordia Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Chordia Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Other Stockholders Equity Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Other Stockholders Equity
3,432.79 5,432.87 25.93 2.94

Chordia Therapeutics Quarterly Data
Aug21 Aug22 May23 Aug23 May24 Aug24 Feb25
Other Stockholders Equity Get a 7-Day Free Trial 25.93 25.93 25.93 2.94 2.52

Chordia Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Chordia Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordia Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines